Guildford-based medical diagnostics company firm Angle makes two senior appointments

By Peter Davison

6 June 2023

Share

The Business Magazine article image for: Guildford-based medical diagnostics company firm Angle makes two senior appointments

Andrew Newland

Guildford-based medical diagnostics company firm Angle has appointed Brett Swansiger as chief commercial officer and Karen Miller as chief scientific officer.

The firm is focused on the cancer and fetal health markets, and a leading expert in cancer cell capture and analysis from liquid biopsies.

Brett brings over 20 years of commercial leadership, international business development, business-to-business sales and US-managed care contracting experience within the molecular diagnostic and pharmaceutical industries.

Most recently, Brett was CCO at DxTerity Diagnostics where he built out the commercial organisation, established new business relationships and initiated payer strategies. Brett began his life sciences career at Bristol Myers Squibb before moving into senior commercial positions at Prometheus Laboratories, Agendia Inc, and MDxHealth.

Brett is based in the United States and is responsible for managing pharma and clinical services sales, building corporate partnerships globally, and for guiding US research and clinical product sales and payer engagement.

He also supports the products business teams responsible for direct sales of products and sales through Angle's growing distributor network.

Karen has over 30 years of experience in the pharmaceutical industry with an extensive background in drug discovery and clinical development as well as in-depth knowledge of molecular analysis techniques used for cancer analysis in a wide range of indications with multiple modalities.

She brings a strong network of relationships within the pharmaceutical and companion diagnostic industries. Karen was most recently CSO at Ixaka where she led research strategy, guided major projects through to the clinic and participated in partnership and licensing activities.

Previous experience includes senior executive positions with Vertex Pharmaceuticals, UCB Pharma, GlaxoSmithKline and Adaptimmune. At ANGLE, Karen is responsible for external interactions with pharma customers, medtech partner companies and laboratory customers to drive the widespread adoption of the Parsortix system as well as providing overall scientific leadership for the company.

Angle Founder and Chief Executive, Andrew Newland, commented: "I am delighted to be able to welcome these two highly accomplished individuals to the Angle management team.

"Brett and Karen bring valuable skills and networks that will play a key role in helping us deliver on our strategic and commercial objectives. I look forward to working closely with them as we continue to build commercial momentum."

By Peter Davison

Peter Davison is deputy editor of The Business Magazine. He has spent his life in journalism – doing work experience in newsrooms in and around Bristol while still at school, and landing his first job on a local newspaper aged 19. By 28 he was the youngest newspaper editor in the country.

An early advocate of online news, he spent the first years of the 2000s telling his bosses that the internet posed both the biggest opportunity and greatest threat to the newspaper industry and the art of journalism. He was right on both counts.

Since 2006 he has enjoyed a career as a freelance journalist. He lives in rural Wiltshire with one wife, two children, and three cats.